Overview
Dr. Gilbride is an investigator involved in clinical research trials in radiation oncology focused on head and neck cancers and breast cancer.
Dr. Gilbride is rated as an Experienced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Breast Cancer, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Angiosarcoma.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
750 Wellington Avenue, Grand Junction, CO 81501
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Cancer Centers Of Colorado - St. Mary's Regional Hospital (Rad Onc)
Dr. Kristen Riegert holds a Bachelor of Science in Biology from Pacific University in Forest Grove, OR, and a Doctor of Medicine from Oregon Health & Science University in Portland. She completed an internal medicine internship with Providence Portland Medical Center and a radiation and oncology residency with the University of Arizona in Tucson. In 2014, Dr. Riegert began working as a radiation oncologist at a Walla Walla, WA hospital. She spent the next two decades there. In 2024, she moved to Grand Junction, CO, and joined Intermountain Health.She enjoys hiking, camping, and exploring the outdoors with her sons when she is not at work. Dr. Riegert is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Angiosarcoma.
Vernon King is a Radiation Oncologist in Grand Junction, Colorado. Dr. King is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Anaplastic Thyroid Cancer, Thyroid Cancer, Primitive Neuroectodermal Tumor (PNET), and Posterior Fossa Tumor.
Douglas Rock is a Radiation Oncologist in Grand Junction, Colorado. Dr. Rock is rated as an Advanced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Anal Cancer. Dr. Rock is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Gilbride isAdvanced. Learn about Breast Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Gilbride isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adenoid Cystic CarcinomaDr. Gilbride isExperienced. Learn about Adenoid Cystic Carcinoma.
- AngiosarcomaDr. Gilbride isExperienced. Learn about Angiosarcoma.
- Cervical CancerDr. Gilbride isExperienced. Learn about Cervical Cancer.
- Fibrodysplasia Ossificans ProgressivaDr. Gilbride isExperienced. Learn about Fibrodysplasia Ossificans Progressiva.
- HER-2 Positive Breast CancerDr. Gilbride isExperienced. Learn about HER-2 Positive Breast Cancer.